NGHIÊN CỨU TÌNH HÌNH KIỂM SOÁT MỘT SỐ YẾU TỐ NGUY CƠ TIM MẠCH CỦA BỆNH NHÂN NHỒI MÁU CƠ TIM CẤP ĐIỀU TRỊ TẠI BỆNH VIỆN NHÂN DÂN 115 SAU 3 THÁNG

Việt Trần Quốc; Hải Nguyễn Đức; Lê Nguyễn Văn

doi:10.59354/ydth175.2023.196

Keywords:

Acute myocardial infarction, cardiovascular risk factors

Abstract

Objectives: Study on the control proportion of LDL-C, hypertension, diabetes mellitus and smoking in patients with acute myocardial infarction after 3 months, with comparison between medical treatment and coronary intervention groups.

Subjects: 157 patients with acute myocardial infarction, including 82 patients treated by medical treatment and 75 patients treated by coronary intervention.

Methods: prospective and cross-sectional study and longitudinal follow-up study after 3 months of treatment.

Results: The proportion of patients with hypertension, diabetes mellitus, dyslipidemia and smoking were 65%; 16.7%, 82.8%, 46.2%, respectively. The differences of risk factor distribution between medical treatment and coronary intervention groups were not statistically significant (with p > 0.05).

The proportion of hypertension, diabetes mellitus, dyslipidemia and smoking control of patients with acute myocardial infarction were 76.5%, 57.7%, 54.6%, 72.2%, respectively. The proportion of risk factor control between medical treatment and intervention groups were not statistically significant (with p > 0.05).

Consclusions: The control of cardiovascular risk factors of patients with acute myocardial infarction after 3 months of treatment was not good. The proportion of risk factor control between medical treatment and intervention groups were not statistically significant (with p > 0.05).

References

Mollon, L, and S, Bhattacharjee, Health related quality of life among myocardial infarction survivors in the United States: a propensity score matched analysis, Health Qual Life Outcomes, 2017, 15(1): p, 235.

Shiraishi, J, et al., Influence of previous myocardial infarction site on in-hospital outcome after primary percutaneous coronary intervention for repeat myocardial infarction, J Cardiol, 2010, 55(1): p, 77-83.

Thygesen, K,, et al,, Fourth Universal Definition of Myocardial Infarction (2018), Journal of the American College of Cardiology, 2018, 72(18): p, 2231-2264.

Félix-Redondo, F,J,, et al,, Risk factors and therapeutic coverage at 6 years in patients with previous myocardial infarction: the CASTUO study, Open Heart, 2016, 3(1): p, e000368.

Nguyễn Thụy Trang, Khảo sát tình hình kiểm soát các yếu tố nguy cơ tim mạch sau can thiệp mạch vành, 2014, Đại học Y dược thành phố Hồ Chí Minh, p, 76.

Lê Huy Thạch, Yếu tố tiên lượng trong nhồi máu cơ tim cấp tại khoa HSCC Bệnh viện Ninh Thuận, 2012.

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme, Eur Heart J, 2001, 22(7): p, 554-72.

Kotseva, K,, et al,, EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, Eur J Cardiovasc Prev Rehabil, 2009, 16(2): p, 121-37.

Võ Thị Dễ, Nghiên cứu sự tuân thủ điều trị của bệnh nhân động mạch vành đã được can thiệp, 2012, Đai học Y dược thành phố Hồ Chí Minh, p, 145.

Jankowski, P,, et al,, Secondary prevention of coronary artery disease in contemporary clinical practice, Cardiol J, 2015, 22(2): p, 219-26.

Andrikopoulos, G,, et al,, Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome--results from the countrywide TARGET study, Int J Cardiol, 2013, 168(2): p, 922-7.

Trương Hoàng Anh Thơ, Khảo sát tình hình theo dõi và điều trị bệnh nhân sau nhồi máu cơ tim cấp tại Bệnh viện Nguyễn Tri Phương từ năm 2003 đến 2005, 2006, Đại học Y dược thành phố Hồ Chí Minh, p, 76.